Related references
Note: Only part of the references are listed.Open-label tofacitinib and double-blind atorvastatin in rheumatoid arthritis patients: a randomised study
Iain B. McInnes et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Carotid ultrasound is useful for the cardiovascular risk stratification of patients with rheumatoid arthritis: results of a population-based study
Alfonso Corrales et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
HDL protein composition alters from proatherogenic into less atherogenic and proinflammatory in rheumatoid arthritis patients responding to rituximab
Hennie G. Raterman et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Influence of anti-TNF patient warning regarding avoidance of high risk foods on rates of listeria and salmonella infections in the UK
Rebecca Davies et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Treatment to lipid targets in patients with inflammatory joint diseases in a preventive cardio-rheuma clinic
Silvia Rollefstad et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Microscopic gut inflammation in axial spondyloarthritis: a multiparametric predictive model
Liesbet Van Praet et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Could cardiovascular disease risk stratification and management in rheumatoid arthritis be enhanced?
Patrick H. Dessein et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Changes in Lipoproteins Associated With Methotrexate or Combination Therapy in Early Rheumatoid Arthritis: Results From the Treatment of Early Rheumatoid Arthritis Trial
Iris Navarro-Millan et al.
ARTHRITIS AND RHEUMATISM (2013)
High-density Lipoprotein Profiling Changes in Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor Inhibitors: A Cohort Study
Anna Jamnitski et al.
JOURNAL OF RHEUMATOLOGY (2013)
Carotid Plaque Characteristics and Disease Activity in Rheumatoid Arthritis
Anne G. Semb et al.
JOURNAL OF RHEUMATOLOGY (2013)
Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial
Cem Gabay et al.
LANCET (2013)
Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm
Jamie Robertson et al.
NATURE REVIEWS RHEUMATOLOGY (2013)
Challenges of Cardiovascular Risk Assessment in the Routine Rheumatology Outpatient Setting: An Observational Study of 110 Rheumatoid Arthritis Patients
L. Gossec et al.
ARTHRITIS CARE & RESEARCH (2013)
Lipid and Lipoprotein Levels and Trend in Rheumatoid Arthritis Compared to the General Population
Katherine P. Liao et al.
ARTHRITIS CARE & RESEARCH (2013)
INVESTIGATING THE CELLULAR COMPOSITION OF LYMPH NODES IN PRECLINICAL AND EARLY INFLAMMATORY ARTHRITIS: A FEASIBILITY STUDY
L. G. M. van Baarsen et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Effect of TNF inhibitors on lipid profile in rheumatoid arthritis: a systematic review with meta-analysis
Claire Immediato Daien et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis
Christina Charles-Schoeman et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Proteomic profiling following immunoaffinity capture of high-density lipoprotein: Association of acute-phase proteins and complement factors with proinflammatory high-density lipoprotein in rheumatoid arthritis
Junji Watanabe et al.
ARTHRITIS AND RHEUMATISM (2012)
Effect of Intensive Lipid-Lowering Therapy on Cardiovascular Outcome in Patients With and Those Without Inflammatory Joint Disease
Anne Grete Semb et al.
ARTHRITIS AND RHEUMATISM (2012)
Assessment of cardiovascular risk in rheumatoid arthritis: impact of the new EULAR recommendations on the score cardiovascular risk index
Carmen Gomez-Vaquero et al.
CLINICAL RHEUMATOLOGY (2012)
Health benefits of high-density lipoproteins in preventing cardiovascular diseases
Hicham Berrougui et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2012)
Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies
Nadeem Sarwar et al.
LANCET (2012)
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis
Daniel I. Swerdlow et al.
LANCET (2012)
Cardiovascular safety of biologic therapies for the treatment of RA
Jeffrey D. Greenberg et al.
NATURE REVIEWS RHEUMATOLOGY (2012)
Validated methods for assessment of subclinical atherosclerosis in rheumatology
Gyoergy Kerekes et al.
NATURE REVIEWS RHEUMATOLOGY (2012)
Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis
Roy Fleischmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis
Ronald F. van Vollenhoven et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
Gregory G. Schwartz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Dyslipidemia and changes in lipid profiles associated with rheumatoid arthritis and initiation of anti-tumor necrosis factor therapy
Jeffrey R. Curtis et al.
ARTHRITIS CARE & RESEARCH (2012)
Anti-tumor necrosis factor therapy improves insulin resistance, beta cell function and insulin signaling in active rheumatoid arthritis patients with high insulin resistance
Ilias Stagakis et al.
ARTHRITIS RESEARCH & THERAPY (2012)
Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis
Jeffrey D. Greenberg et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Towards improving cardiovascular risk management in patients with rheumatoid arthritis: the need for accurate risk assessment
Cynthia S. Crowson et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study
Jesper Lindhardsen et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease
Elena Myasoedova et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Tocilizumab Inhibits Structural Joint Damage in Rheumatoid Arthritis Patients With Inadequate Responses to Methotrexate Results From the Double-Blind Treatment Phase of a Randomized Placebo-Controlled Trial of Tocilizumab Safety and Prevention of Structural Joint Damage at One Year
Joel M. Kremer et al.
ARTHRITIS AND RHEUMATISM (2011)
Carotid Atherosclerosis Predicts Incident Acute Coronary Syndromes in Rheumatoid Arthritis
Matthew R. Evans et al.
ARTHRITIS AND RHEUMATISM (2011)
The metabolic syndrome: The crossroads between rheumatoid arthritis and cardiovascular risk
Elisa Gremese et al.
AUTOIMMUNITY REVIEWS (2011)
Co-morbidities in established rheumatoid arthritis
Nicola J. Gullick et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2011)
Cytokines as Therapeutic Targets to Reduce Cardiovascular Risk in Chronic Inflammation
Ashley M. Miller et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Traditional cardiovascular risk factors in rheumatoid arthritis: A meta-analysis
Jean-Frederic Boyer et al.
JOINT BONE SPINE (2011)
Tocilizumab Monotherapy Reduces Arterial Stiffness as Effectively as Etanercept or Adalimumab Monotherapy in Rheumatoid Arthritis: An Open-label Randomized Controlled Trial
Kensuke Kume et al.
JOURNAL OF RHEUMATOLOGY (2011)
Progress and challenges in translating the biology of atherosclerosis
Peter Libby et al.
NATURE (2011)
The immune system in atherosclerosis
Goran K. Hansson et al.
NATURE IMMUNOLOGY (2011)
Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review
Sarah L. Westlake et al.
RHEUMATOLOGY (2011)
Intensive lipid lowering in patients with rheumatoid arthritis and previous myocardial infarction: an explorative analysis from the incremental decrease in endpoints through aggressive lipid lowering (IDEAL) trial
Anne G. Semb et al.
RHEUMATOLOGY (2011)
Effects of the anti-interleukin-6 receptor antibody, tocilizumab, on serum lipid levels in patients with rheumatoid arthritis
Shin-ya Kawashiri et al.
RHEUMATOLOGY INTERNATIONAL (2011)
The Effect of TNF-alpha Blocking Therapy on Lipid Levels in Rheumatoid Arthritis: A Meta-Analysis
Alper M. van Sijl et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2011)
Carotid Intima Media Thickness in Rheumatoid Arthritis as Compared to Control Subjects: A Meta-Analysis
Alper M. van Sijl et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2011)
Systematic Review and Meta-Analysis: Anti-Tumor Necrosis Factor α Therapy and Cardiovascular Events in Rheumatoid Arthritis
Cheryl Barnabe et al.
ARTHRITIS CARE & RESEARCH (2011)
Integrated safety in tocilizumab clinical trials
Michael H. Schiff et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study
Lena Innala et al.
ARTHRITIS RESEARCH & THERAPY (2011)
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
M. J. L. Peters et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) Study
A. G. Semb et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
High risk of clinical cardiovascular events in rheumatoid arthritis: Levels of associations of myocardial infarction and stroke through a systematic review and meta-analysis
Christophe Meune et al.
ARCHIVES OF CARDIOVASCULAR DISEASES (2010)
Risk factors and early detection of atherosclerosis in rheumatoid arthritis
Lodewijk De Groot et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2010)
The AMBITION trial: tocilizumab monotherapy for rheumatoid arthritis
Graeme Jones
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2010)
Rapid increase in myocardial infarction risk following diagnosis of rheumatoid arthritis amongst patients diagnosed between 1995 and 2006
M. E. Holmqvist et al.
JOURNAL OF INTERNAL MEDICINE (2010)
Longterm Safety of Patients Receiving Rituximab in Rheumatoid Arthritis Clinical Trials
Ronald F. van Vollenhoven et al.
JOURNAL OF RHEUMATOLOGY (2010)
Safety and efficacy profiles of tocilizumab monotherapy in Japanese patients with rheumatoid arthritis: meta-analysis of six initial trials and five long-term extensions
Norihiro Nishimoto et al.
MODERN RHEUMATOLOGY (2010)
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
Stephen Kaptoge et al.
LANCET (2010)
Effects of Inhibition of Interleukin-6 Signalling on Insulin Sensitivity and Lipoprotein (A) Levels in Human Subjects with Rheumatoid Diseases
Olaf Schultz et al.
PLOS ONE (2010)
The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review
Sarah L. Westlake et al.
RHEUMATOLOGY (2010)
Atherosclerosis in early rheumatoid arthritis: very early endothelial activation and rapid progression of intima media thickness
Anna Sodergren et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Infliximab improves vascular stiffness in patients with rheumatoid arthritis
M. Wong et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research
C. Salliot et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Sustained changes in lipid profile and macrophage migration inhibitory factor levels after anti-tumour necrosis factor therapy in rheumatoid arthritis
C. A. Wijbrandts et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Anti-inflammatory therapy with tumour necrosis factor alpha inhibitors improves high-density lipoprotein cholesterol antioxidative capacity in rheumatoid arthritis patients
C. Popa et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions
E. Choy et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
No Increased Occurrence of Ischemic Heart Disease Prior to the Onset of Rheumatoid Arthritis Results From Two Swedish Population-Based Rheumatoid Arthritis Cohorts
Marie E. Holmqvist et al.
ARTHRITIS AND RHEUMATISM (2009)
Does Rheumatoid Arthritis Equal Diabetes Mellitus as an Independent Risk Factor for Cardiovascular Disease? A Prospective Study
Mike J. L. Peters et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
Inflammatory Mediators and Premature Coronary Atherosclerosis in Rheumatoid Arthritis
Young Hee Rho et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
A Translational Medicine perspective of the development of torcetrapib: Does the failure of torcetrapib development cast a shadow on future development of lipid modifying agents, HDL elevation strategies or CETP as a viable molecular target for atherosclerosis? A case study of the use of biomarkers and Translational Medicine in atherosclerosis drug discovery and development
Lei Zhao et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Rheumatoid Arthritis - A Model of Systemic Inflammation Driving Atherosclerosis
Ivy A. Ku et al.
CIRCULATION JOURNAL (2009)
Effects of rituximab treatment on endothelial dysfunction, carotid atherosclerosis, and lipid profile in rheumatoid arthritis
Gyoergy Kerekes et al.
CLINICAL RHEUMATOLOGY (2009)
Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT)
Paul M. Ridker
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Role for TNF in atherosclerosis? Lessons from autoimmune disease
Gayle E. McKellar et al.
NATURE REVIEWS CARDIOLOGY (2009)
Levels of C-Reactive Protein Associated with High and Very High Cardiovascular Risk Are Prevalent in Patients with Rheumatoid Arthritis
Jonathan Graf et al.
PLOS ONE (2009)
Arterial stiffness and cumulative inflammatory burden in rheumatoid arthritis: a dose-response relationship independent of established cardiovascular risk factors
Michael A. Crilly et al.
RHEUMATOLOGY (2009)
Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies
Christophe Meune et al.
RHEUMATOLOGY (2009)
Lipid Profiles in Patients with Rheumatoid Arthritis: Mechanisms and the Impact of Treatment
George Steiner et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2009)
Troponin I levels in preeclampsia - The reply
Dominique Joyal et al.
AMERICAN JOURNAL OF MEDICINE (2008)
Role of inflammation in atherosclerosis associated with rheumatoid arthritis
Peter Libby
AMERICAN JOURNAL OF MEDICINE (2008)
IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial
P. Emery et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
C-reactive protein inhibits cholesterol efflux from human macrophage-derived foam cells
Xinwen Wang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Interleukin-6 Receptor Inhibition With Tocilizumab Reduces Disease Activity in Rheumatoid Arthritis With Inadequate Response to Disease-Modifying Antirheumatic Drugs The Tocilizumab in Combination With Traditional Disease-Modifying Antirheumatic Drug Therapy Study
Mark C. Genovese et al.
ARTHRITIS AND RHEUMATISM (2008)
Inflammation-associated insulin resistance - Differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms
Cecilia P. Chung et al.
ARTHRITIS AND RHEUMATISM (2008)
Risk of Cardiovascular Mortality in Patients With Rheumatoid Arthritis: A Meta-Analysis of Observational Studies
J. Antonio Avina-Zubieta et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Human C-reactive protein promotes oxidized low density lipoprotein uptake and matrix metalloproteinase-9 release in Wistar rats
U. Singh et al.
JOURNAL OF LIPID RESEARCH (2008)
Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial
Josef S. Smolen et al.
LANCET (2008)
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
Daniel Tracey et al.
PHARMACOLOGY & THERAPEUTICS (2008)
Long-term interleukin-6 levels and subsequent risk of coronary heart disease: Two new prospective studies and a systematic review
John Danesh et al.
PLOS MEDICINE (2008)
Tight control in the treatment of rheumatoid arthritis: efficacy and feasibility
M. F. Bakker et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): Evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab
Norihiro Nishimoto et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor α therapy -: Results from the British Society for Rheumatology Biologics Register
W. G. Dixon et al.
ARTHRITIS AND RHEUMATISM (2007)
Differential association of hemoglobin with proinflammatory high density lipoproteins in Atherogenic/Hyperlipidemic mice - A novel biomarker of atherosclerosis
Junji Watanabe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis
M. J. L. Peters et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Response to anti-tumour necrosis factor alpha blockade is associated with reduction of carotid intima-media thickness in patients with active rheumatoid arthritis
F. Del Porto et al.
RHEUMATOLOGY (2007)
Effects of tumor necrosis factor blockade on cardiovascular risk factors in psoriatic arthritis - A double-blind, placebo-controlled study
Naveed Sattar et al.
ARTHRITIS AND RHEUMATISM (2007)
Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate
R. N. Maini et al.
ARTHRITIS AND RHEUMATISM (2006)
Errors that result from using the TC/HDL C ratio rather than the apoB/apoA-I ratio to identify the lipoprotein-related risk of vascular disease
AD Sniderman et al.
JOURNAL OF INTERNAL MEDICINE (2006)
Dyslipidemia in the critically ill
PE Marik
CRITICAL CARE CLINICS (2006)
Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study
Vokko P. van Halm et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Relative contribution of cardiovascular risk factors and rheumatoid arthritis clinical manifestations to atherosclerosis
I del Rincón et al.
ARTHRITIS AND RHEUMATISM (2005)
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality - An individual participant meta-analysis
J Danesh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Serum lipids and disease severity in children with severe meningococcal sepsis
CL Vermont et al.
CRITICAL CARE MEDICINE (2005)
Vascular comorbidity in rheumatoid arthritis: potential mechanisms and solutions
N Sattar et al.
CURRENT OPINION IN RHEUMATOLOGY (2005)
Cardiovascular Death in Rheumatoid Arthritis A Population-Based Study
Hilal Maradit-Kremers et al.
ARTHRITIS AND RHEUMATISM (2005)
Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis
C Popa et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of HMG-CoA reductase inhibitors
T Wæhre et al.
CIRCULATION (2004)
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
S Yusuf et al.
LANCET (2004)
Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment
BJ Ansell et al.
CIRCULATION (2003)
Inflammatory markers and cardiovascular disease (The Health, Aging and Body Composition [Health ABC] Study)
M Cesari et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Cholesterol measures to identify and treat individuals at risk for coronary heart disease
S Natarajan et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2003)
Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects
I del Rincón et al.
ARTHRITIS AND RHEUMATISM (2003)
Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis
DH Solomon et al.
CIRCULATION (2003)
Anti-tumor necrosis factor-α treatment improves endothelial function in patients with rheumatoid arthritis
D Hürlimann et al.
CIRCULATION (2002)
Methotrexate and mortality in patients with rheumatoid arthritis:: a prospective study
HK Choi et al.
LANCET (2002)
HDL and the inflammatory response induced by LDL-derived oxidized phospholipids
M Navab et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men
PM Ridker et al.
CIRCULATION (2000)
LDL subfractions in patients with myocardial infarction:: effect of smoking and β-blocker treatment
TG Theodoraki et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2000)
Share Paper
